331 related articles for article (PubMed ID: 30736852)
21. Vascular complications after orthotopic liver transplantation after neoadjuvant therapy for hilar cholangiocarcinoma.
Mantel HT; Rosen CB; Heimbach JK; Nyberg SL; Ishitani MB; Andrews JC; McKusick MA; Haddock MG; Alberts SR; Gores GJ
Liver Transpl; 2007 Oct; 13(10):1372-81. PubMed ID: 17427173
[TBL] [Abstract][Full Text] [Related]
22. Cases of spontaneous tumor regression in hepatobiliary cancers: implications for immunotherapy?
Parks AL; McWhirter RM; Evason K; Kelley RK
J Gastrointest Cancer; 2015 Jun; 46(2):161-5. PubMed ID: 25662892
[No Abstract] [Full Text] [Related]
23. Current controversies in cholangiocarcinoma.
Hoyos S; Navas MC; Restrepo JC; Botero RC
Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1461-1467. PubMed ID: 28756216
[TBL] [Abstract][Full Text] [Related]
24. Cholangiocarcinoma metastatic to the neck: first report of a case.
Hardeman SH; Collins B; Lowe VJ; Solomon H; Stack BC
Ear Nose Throat J; 2002 Nov; 81(11):776-8. PubMed ID: 12472031
[TBL] [Abstract][Full Text] [Related]
25. Future directions in the treatment of cholangiocarcinoma.
Zhu AX
Best Pract Res Clin Gastroenterol; 2015 Apr; 29(2):355-61. PubMed ID: 25966434
[TBL] [Abstract][Full Text] [Related]
26. Immunometabolism: A novel perspective of liver cancer microenvironment and its influence on tumor progression.
Zhang Q; Lou Y; Bai XL; Liang TB
World J Gastroenterol; 2018 Aug; 24(31):3500-3512. PubMed ID: 30131656
[TBL] [Abstract][Full Text] [Related]
27. Screening and diagnosis of cholangiocarcinoma in patients with primary sclerosing cholangitis.
Jesudian AB; Jacobson IM
Rev Gastroenterol Disord; 2009; 9(2):E41-7. PubMed ID: 19668124
[TBL] [Abstract][Full Text] [Related]
28. A review of the clinical diagnosis and therapy of cholangiocarcinoma.
Yao D; Kunam VK; Li X
J Int Med Res; 2014 Feb; 42(1):3-16. PubMed ID: 24366497
[TBL] [Abstract][Full Text] [Related]
29. Aberrant expression of B7-H4 correlates with poor prognosis and suppresses tumor-infiltration of CD8+ T lymphocytes in human cholangiocarcinoma.
Zhao X; Guo F; Li Z; Jiang P; Deng X; Tian F; Li X; Wang S
Oncol Rep; 2016 Jul; 36(1):419-27. PubMed ID: 27177355
[TBL] [Abstract][Full Text] [Related]
30. Predictors of disease recurrence following neoadjuvant chemoradiotherapy and liver transplantation for unresectable perihilar cholangiocarcinoma.
Heimbach JK; Gores GJ; Haddock MG; Alberts SR; Pedersen R; Kremers W; Nyberg SL; Ishitani MB; Rosen CB
Transplantation; 2006 Dec; 82(12):1703-7. PubMed ID: 17198263
[TBL] [Abstract][Full Text] [Related]
31. Aberrant expression of GATA binding protein 6 correlates with poor prognosis and promotes metastasis in cholangiocarcinoma.
Tian F; Li D; Chen J; Liu W; Cai L; Li J; Jiang P; Liu Z; Zhao X; Guo F; Li X; Wang S
Eur J Cancer; 2013 May; 49(7):1771-80. PubMed ID: 23313142
[TBL] [Abstract][Full Text] [Related]
32. Liver Transplant for Cholangiocarcinoma.
Zamora-Valdes D; Heimbach JK
Gastroenterol Clin North Am; 2018 Jun; 47(2):267-280. PubMed ID: 29735023
[TBL] [Abstract][Full Text] [Related]
33. A nomogram to predict lymph node metastasis before resection in intrahepatic cholangiocarcinoma.
Meng ZW; Lin XQ; Zhu JH; Han SH; Chen YL
J Surg Res; 2018 Jun; 226():56-63. PubMed ID: 29661289
[TBL] [Abstract][Full Text] [Related]
34. Cholangiocarcinoma.
Khan AS; Dageforde LA
Surg Clin North Am; 2019 Apr; 99(2):315-335. PubMed ID: 30846037
[TBL] [Abstract][Full Text] [Related]
35. γδ cell-based immunotherapy for cancer.
Lo Presti E; Corsale AM; Dieli F; Meraviglia S
Expert Opin Biol Ther; 2019 Sep; 19(9):887-895. PubMed ID: 31220420
[No Abstract] [Full Text] [Related]
36. The diagnosis and treatment of cholangiocarcinoma.
Vogel A; Wege H; Caca K; Nashan B; Neumann U
Dtsch Arztebl Int; 2014 Oct; 111(44):748-54. PubMed ID: 25412632
[TBL] [Abstract][Full Text] [Related]
37. [Biopathological characteristics of hilar cholangiocarcinoma and the clinical significance].
Yu WL; Zhang YJ; Dong H; Yu H; Xian ZH; Wu MC; Cong WM
Zhonghua Wai Ke Za Zhi; 2009 Aug; 47(15):1162-6. PubMed ID: 20021908
[TBL] [Abstract][Full Text] [Related]
38. The role of surgery and adjuvant therapy in lymph node-positive cancers of the gallbladder and intrahepatic bile ducts.
Tran Cao HS; Zhang Q; Sada YH; Chai C; Curley SA; Massarweh NN
Cancer; 2018 Jan; 124(1):74-83. PubMed ID: 28841223
[TBL] [Abstract][Full Text] [Related]
39. Cholangiocarcinoma Prognosis Varies over Time Depending on Tumor Site and Pathology.
Kaneko R; Sato Y; Kobayashi Y
J Gastrointestin Liver Dis; 2018 Mar; 27(1):59-66. PubMed ID: 29557416
[TBL] [Abstract][Full Text] [Related]
40. EUS-FNA in unresectable cholangiocarcinoma: a novel indication.
Pollack MJ; Gholam PM; Chak A
Gastrointest Endosc; 2008 Mar; 67(3):444-5. PubMed ID: 18294505
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
